首页> 外文OA文献 >Precision orthotics: optimising ankle foot orthoses to improve gait in patients with neuromuscular diseases; protocol of the PROOF-AFO study, a prospective intervention study
【2h】

Precision orthotics: optimising ankle foot orthoses to improve gait in patients with neuromuscular diseases; protocol of the PROOF-AFO study, a prospective intervention study

机译:精密矫形器:优化踝足矫形器以改善神经肌肉疾病患者的步态; PROOF-AFO研究的方案,一项前瞻性干预研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction: In patients with neuromuscular disorders and subsequent calf muscle weakness, metabolic walking energy cost (EC) is nearly always increased, which may restrict walking activity in daily life. To reduce walking EC, a spring-like ankle-foot-orthosis (AFO) can be prescribed. However, the reduction in EC that can be obtained from these AFOs is stiffness dependent, and it is unknown which AFO stiffness would optimally support calf muscle weakness. The PROOF-AFO study aims to determine the effectiveness of stiffness-optimised AFOs on reducing walking EC, and improving gait biomechanics and walking speed in patients with calf muscle weakness, compared to standard, non-optimised AFOs. A second aim is to build a model to predict optimal AFO stiffness. Methods and analysis: A prospective intervention study will be conducted. In total, 37 patients with calf muscle weakness who already use an AFO will be recruited. At study entry, participants will receive a new custom-made spring-like AFO of which the stiffness can be varied. For each patient, walking EC (primary outcome), gait biomechanics and walking speed (secondary outcomes) will be assessed for five stiffness configurations and the patient's own (standard) AFO. On the basis of walking EC and gait biomechanics outcomes, the optimal AFO stiffness will be determined. After wearing this optimal AFO for 3 months, walking EC, gait biomechanics and walking speed will be assessed again and compared to the standard AFO. Ethics and dissemination: The Medical Ethics Committee of the Academic Medical Centre in Amsterdam has approved the study protocol. The study is registered at the Dutch trial register (NTR 5170). The PROOF-AFO study is the first to compare stiffness-optimised AFOs with usual care AFOs in patients with calf muscle weakness. The results will also provide insight into factors that influence optimal AFO stiffness in these patients. The results are necessary for improving orthotic treatment and will be disseminated through international peer-reviewed journals and scientific conferences
机译:简介:在患有神经肌肉疾病和随后的小腿肌肉无力的患者中,代谢步行能量成本(EC)几乎总是增加,这可能会限制日常生活中的步行活动。为了减少步行EC,可以规定弹簧状踝足矫形器(AFO)。然而,可以从这些AFO获得的EC的降低取决于刚度,并且未知哪种AFO刚度可以最佳地支持小腿肌肉无力。与标准的非优化AFO相比,PROOF-AFO研究旨在确定刚度优化的AFO在降低小腿肌无力,改善步态生物力学和行走速度方面的有效性。第二个目标是建立一个预测最佳AFO刚度的模型。方法和分析:将进行前瞻性干预研究。总共将招募37位已经使用AFO的小腿肌无力患者。在参加研究时,参加者将获得新的定制弹簧状AFO,其刚度可以变化。对于每位患者,将评估其五种刚度配置和患者自身(标准)AFO的步行EC(主要结果),步态生物力学和步行速度(次要结果)。根据步行EC和步态生物力学结果,将确定最佳AFO刚度。佩戴此最佳AFO 3个月后,将再次评估步行EC,步态生物力学和步行速度,并将其与标准AFO进行比较。伦理与传播:阿姆斯特丹学术医学中心的医学伦理委员会已批准了研究方案。该研究已在荷兰试验注册处注册(NTR 5170)。 PROOF-AFO研究是第一个将刚度优化的AFO与小腿肌无力患者的常规护理AFO进行比较的研究。该结果还将提供影响这些患者最佳AFO硬度的因素的见解。研究结果对于改善矫形器治疗是必要的,并将通过国际同行评审期刊和科学会议进行传播

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号